Parkinson’s Disease and Aging


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Parkinson’s disease (PD) is one of the most severe human neurodegenerative diseases. It is mainly represented by its sporadic form with a multifactorial nature and is commonly diagnosed in persons over 65 years of age. Current data on the molecular mechanisms of PD development and their connection with aging processes are given in the review. The mechanisms of conformational control and selective degradation of proteins in the cell, as well as possible trigger factors initiating the cascade of pathological reactions, have been analyzed. Prospects for the solution of the problem of the elimination of basic causes of PD incurability (late diagnosis and ineffective treatment) related to determination of reliable nonmotor markers of preclinical identification and the correction of early disorder of integrative brain functions are evaluated. The focus is on an analysis of early sleep and behavior disorders in PD and aging. The currently known endogenous neuroprotective factors capable of inhibiting the neurodegenerative process in this disease are considered.

Об авторах

A. Chesnokova

Sechenov Institute of Evolutionary Physiology and Biochemistry

Email: pastukh36@mail.ru
Россия, St. Petersburg, 194223

I. Ekimova

Sechenov Institute of Evolutionary Physiology and Biochemistry

Автор, ответственный за переписку.
Email: irina-ekimova@mail.ru
Россия, St. Petersburg, 194223

Yu. Pastukhov

Sechenov Institute of Evolutionary Physiology and Biochemistry

Автор, ответственный за переписку.
Email: pastukh36@mail.ru
Россия, St. Petersburg, 194223


© Pleiades Publishing, Ltd., 2019

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах